|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o BioAdvance, a Philadelphia-based biotechnology greenhouse of southeastern Pennsylvania, selected seven recipients for a first round of funding provided by its $20 million Greenhouse Fund, which invests in early stage human health technology companies in the area. Among the recipients are Eagle Vision Pharmaceutical Corp., which is developing agents to enhance MRI; Integral Molecular, whose technology is designed to simplify drug discovery; MacroArray Technologies Inc., which is developing diagnostic markers and therapeutics for a variety of cancers; RetinaPharma Technologies Inc., which is working on vision disorders; and Spliceomix Inc., which is developing vaccines and ...
Related newspaper, magazine, and journal articles:
|
|
Article: Turning Pennies into dollars: (OTCBB:NWBO) Northwest ...
M2 Presswire;
October 2, 2008 ;
700+ words
... ... into dollars: (OTCBB:NWBO) Northwest Biotherapeutics, Inc.(C)1994-2008 M2 COMMUNICATIONS ... otc/nwbo (OTCBB:NWBO) Northwest Biotherapeutics, Inc. BETHESDA, Md. -- Northwest Biotherapeutics, Inc. , recently announced that ...
|
|